Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma

• Main Authors: Mustafa, Nurulhuda, Nee, Adina Huey Fang, Chooi, Jing Yuan, Toh, Sabrina Hui Min, Chung, Tae-Hoon, Selvarajan, Viknesvaran, Fan, Shuangyi, Ng, Siok Bian, Poon, Michelle, Chan, Esther, Lee, Joanne, Chee, Yen Lin, Jeyasekharan, Anand D, Zhou, Longen, Yang, Jennifer, Chng, Wee Joo
• Other Authors: MEDICINE
• Format: Article
• Language: English
• Published: BMJ PUBLISHING GROUP 2021
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; Immunology; antibodies; neoplasm; drug evaluation; preclinical; hematologic neoplasms; immunotherapy; MEMBRANE COFACTOR PROTEIN; DECAY-ACCELERATING FACTOR; MULTIPLE-MYELOMA; CD38 EXPRESSION; NASAL TYPE; COMPLEMENT REGULATORS; ANTITUMOR-ACTIVITY; HEMATOPOIETIC SCT; TARGETING CD38; ANTIBODY
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/206598
• Institution: National University of Singapore

10.1136/jitc-2020-002123